S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TERN Terns Pharmaceuticals Inc

6.02

0.14 (2.38%)

Pre Market

Last Updated: 08:25:08

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals Inc News

Form 8-K - Current report
Monday 18 November 2024 (1 week ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
Monday 18 November 2024 (1 week ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates
Tuesday 12 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 24 October 2024 (1 month ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Monday 7 October 2024 (2 months ago) • GlobeNewswire Inc.

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Thursday 12 September 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 12 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 11 September 2024 (3 months ago) • Edgar (US Regulatory)

More Terns Pharmaceuticals Inc News Articles

BNP Paribas Issuance

BNP Paribas Issuance BV

Bnp Paribas Issuance

BNP Paribas Issuance

Vanguard Ftse Developed ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions